SCHEMBL5763306

SCHEMBL5763306

Cn1c(=O)c(-c2c(Cl)cccc2Cl)cc2cnc(Nc3cccnc3)nc21

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FGFR1 P11362 14/20 1.00
EGFR P00533 11/20 1.00
SRC P12931 12/20 0.83
WEE1 P30291 3/20 0.82
FGFR2 P21802 2/20 0.82
FGFR4 P22455 2/20 0.82
FGFR3 P22607 2/20 0.82
ABL1 P00519 10/20 0.76
PDGFRB P09619 10/20 0.76
PDGFRA P16234 10/20 0.76
MAPK14 Q16539 10/20 0.76
KIT P10721 4/20 0.74
BMPR1B O00238 1/20 0.74
STK25 O00506 1/20 0.74
GAK O14976 1/20 0.74
EPHB6 O15197 1/20 0.74
RIPK2 O43353 1/20 0.74
JAK2 O60674 1/20 0.74
STK10 O94804 1/20 0.74
MAP4K4 O95819 1/20 0.74

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL868353 0.91 FGFR1 (1.00) FGFR1EGFRSRCWEE1FGFR2
SCHEMBL1249524 0.90 FGFR1 (1.00) FGFR1EGFRSRCWEE1FGFR2
SCHEMBL29498213 0.90 FGFR1 (0.81) FGFR1EGFRSRCWEE1FGFR2
SCHEMBL20564683 0.90 FGFR1 (0.81) FGFR1EGFRSRCWEE1FGFR2
SCHEMBL13498143 0.88 FGFR1 (0.83) FGFR1EGFRSRCWEE1FGFR2
SCHEMBL5764062 0.87 FGFR1 (1.00) FGFR1EGFRSRCWEE1FGFR2
SCHEMBL2082743 0.87 FGFR1 (1.00) FGFR1EGFRSRCWEE1FGFR2
SCHEMBL2083206 0.87 SRC (1.00) FGFR1EGFRSRCWEE1FGFR2
SCHEMBL5762318 0.87 FGFR1 (1.00) FGFR1EGFRSRCWEE1FGFR2
SCHEMBL5762046 0.86 SRC (1.00) FGFR1EGFRSRCWEE1FGFR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0823908-B1 PYRIDO[2,3-d]PYRIMIDINES FOR INHIBITING PROTEIN TYROSINE KINASE MEDIATED CELLULAR PROLIFERATION WARNER LAMBERT CO (US) 2006-11-02 EP claimed
WO-2005105097-A2 PYRIDOPYRIMIDINES FOR TREATING INFLAMMATORY AND OTHER DISEASES GPC BIOTECH AG (DE) 2005-11-10 WO claimed
EP-0823908-A1 PYRIDO 2,3-d]PYRIMIDINES FOR INHIBITING PROTEIN TYROSINE KINASE MEDIATED CELLULAR PROLIFERATION WARNER-LAMBERT COMPANY (US) 1998-02-18 EP claimed
WO-1996034867-A1 PYRIDO[2,3-d]PYRIMIDINES FOR INHIBITING PROTEIN TYROSINE KINASE MEDIATED CELLULAR PROLIFERATION WARNER-LAMBERT COMPANY (US) 1996-11-07 WO claimed
EP-0823908-B1 PYRIDO[2,3-d]PYRIMIDINES FOR INHIBITING PROTEIN TYROSINE KINASE MEDIATED CELLULAR PROLIFERATION WARNER LAMBERT CO (US) 2006-11-02 EP disclosed
EP-1607415-A1 METHOD FOR PRODUCING MODIFIED POLYOLEFIN SOLUTION Tonen Chemical Corporation (JP) 2005-12-21 EP disclosed
WO-2005105097-A2 PYRIDOPYRIMIDINES FOR TREATING INFLAMMATORY AND OTHER DISEASES GPC BIOTECH AG (DE) 2005-11-10 WO disclosed